Becker's Healthcare March 11, 2024
The American Association of Nurse Anesthesiology has published new guidelines for treating patients using glucagon-like peptide-1 agonists such as Ozempic, Wegovy, Saxenda or Zepbound.
GLP-1 agonists, which were designed to manage Type 2 diabetes but in some cases are approved for weight loss, help patients feel full sooner. However, they also slow gastric emptying, according to a March 11 press release.
Clinical guidelines call for fasting prior to anesthesia because food remaining in a patient’s stomach can cause serious complications such as vomiting and food aspiration.
Due to the risks delayed gastric...
Today's Sponsors
Today's Sponsor